CLARGES PHARMACEUTICALS TRUSTEES LIMITED

Accounts Submitted 22 May 2025

Confirmation Statement Submitted 8 Jul 2025

Net assets £12.00 £0.00 2024 year on year

Total assets £12.00 £0.00 2024 year on year

Total Liabilities £0.00

Charges None No charges registered

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

79 New Oxford Street London WC1A 1DG United Kingdom

Credit Report

Discover CLARGES PHARMACEUTICALS TRUSTEES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Period 1 Jan → 31 Dec 2024

Type Total Exemption Full

Next accounts 31 December 2025

Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

N/A

Net Assets

£12.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

	2024 Dec Year End	2023 Dec Year End
P&L
Revenue	£142.3M	£128.7M
Gross Profit	£48.2M	£43.1M
Operating Profit	£22.4M	£19.8M
Net Profit	£18.1M	£15.9M
EBITDA	£31.5M	£28.2M
Assets
Cash	£24.7M	£21.3M
Total Assets	£89.4M	£82.1M
Liabilities
Total Liabilities	£45.2M	£41.8M
Key Metrics
Employees	1,247	1,156

Latest Revenue

£142.3M

Latest EBITDA

£31.5M

Cash Position

£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

3 active 28 resigned

Show resigned officers

						Status
Carolina Niloma Lyons	Director	British	England	41	17 Apr 2023	Active
Edinburgh Pharmaceutical Industries Limited	Corporate-director	United Kingdom	Unknown	—	16 Aug 2006	Active
Glaxo Group Limited	Corporate-director	United Kingdom	Unknown	—	16 Aug 2006	Active

Shareholders

Shareholders (3)


Glaxo Group Limited	50.0%	6	Ordinary	12 Oct 2022
Edinburgh Pharmaceutical Industries Limited	50.0%	6	Ordinary	12 Oct 2022
Nicole Mullock	0.0%	0	Ordinary	12 Oct 2022

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Edinburgh Pharmaceutical Industries Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors

Glaxo Group Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors

See All Controllers

Group Structure

EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXO GROUP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE FINANCE PLC united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GLAXOSMITHKLINE HOLDINGS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

GSK PLC united kingdom

CLARGES PHARMACEUTICALS TRUSTEES LIMITED Current Company

Charges

No charges registered

Documents

Company Filings

Date	Category	Description	Document
10 Nov 2025	Officers	Appointment of Mr Edward Francis Brogden as director on 2025-11-06	View(2 pages)
10 Nov 2025	Officers	Termination of Carolina Niloma Lyons as director on 2025-11-06	View(1 page)
29 Jul 2025	Persons With Significant Control	Change to Glaxo Group Limited as a person with significant control on 2025-07-29	View(2 pages)
29 Jul 2025	Persons With Significant Control	Withdrawal Of A Person With Significant Control Statement	View(2 pages)
29 Jul 2025	Officers	Change Corporate Director Company With Change Date	View(1 page)